EPOR and acute lymphoblastic leukemia: Erythropoietin receptor rearrangements (EPOR) and JAK2 rearrangements are nearly present in 7–5% of Ph-like ALL cases; these rearrangements activate JAK-STAT signaling without concomitant CRLF2 alterations [15, 33].